v3.22.4
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Jan. 31, 2023
Apr. 30, 2022
Current assets:    
Cash and cash equivalents $ 72,640,218 $ 85,400,656
Prepaid expenses and other current assets 181,008 94,172
Total current assets 72,821,226 85,494,828
Other assets:    
Intangibles 3,549,427 3,549,427
Investment in SG Austria 1,572,193 1,572,193
Other assets 7,688 7,688
Total other assets 5,129,308 5,129,308
Total Assets 77,950,534 90,624,136
Current liabilities:    
Accounts payable 445,935 205,361
Accrued expenses 381,899 499,009
Total current liabilities 827,834 704,370
Total Liabilities 827,834 704,370
Commitments and Contingencies (Notes 6 and 8)
Stockholders' equity:    
Common stock, authorized: 33,333,334 shares, $0.0001 par value; shares issued 21,602,078, shares outstanding 18,209,018 as of January 31, 2023, and 20,721,047 shares issued and outstanding as of April 30, 2022, respectively 2,160 2,072
Additional paid-in capital 202,230,583 201,582,107
Accumulated deficit (115,838,311) (111,648,656)
Treasury stock, at cost, 3,393,060 shares as of January 31, 2023 (9,254,005) 0
Accumulated other comprehensive loss (17,727) (15,757)
Total stockholders' equity 77,122,700 89,919,766
Total Liabilities and Stockholders' Equity $ 77,950,534 $ 90,624,136

Source

v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2023
Jan. 31, 2022
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development costs 45,393 158,039 382,662 436,872
Compensation expense 251,556 267,110 979,694 801,007
Director fees 795,969 84,897 951,031 209,110
Legal and professional 103,180 130,758 2,454,227 601,388
General and administrative 356,885 215,315 784,597 835,936
Total operating expenses 1,552,983 856,119 5,552,211 2,884,313
Loss from operations (1,552,983) (856,119) (5,552,211) (2,884,313)
Other expenses:        
Interest income 635,889 45,459 1,214,562 71,078
Interest expense 0 0 0 (509)
Other income (expense), net 152,958 (630) 147,994 (2,710)
Total other income 788,847 44,829 1,362,556 67,859
Net loss $ (764,136) $ (811,290) $ (4,189,655) $ (2,816,454)
Basic loss per share $ (0.04) $ (0.04) $ (0.21) $ (0.21)
Diluted loss per share $ (0.04) $ (0.04) $ (0.21) $ (0.21)
Weighted average shares outstanding basic 18,995,442 21,667,239 20,051,617 13,538,792
Weighted average shares outstanding diluted 18,995,442 21,667,239 20,051,617 13,538,792

Source

v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Cash flows from operating activities:    
Net loss $ (4,189,655) $ (2,816,454)
Adjustments to reconcile net loss to net cash used in operating activities:    
Other non-cash expense 165,868 0
Stock issued for services 2,278 31,773
Stock issued for compensation 7,334 30,396
Stock-based compensation 638,072 41,893
Change in assets and liabilities:    
Increase in prepaid expenses and other current assets (86,836) (100,970)
Increase in other assets 0 (316)
Increase (decrease) in accounts payable 74,706 (79,399)
Decrease in accrued expenses (117,110) (32,402)
Net cash used in operating activities (3,505,343) (2,925,479)
Cash flows from investing activities:    
Net cash provided by (used in) investing activities 0 0
Cash flows from financing activities:    
Repurchase of common stock (9,254,005) 0
Proceeds from issuance of pre-funded warrants 0 31,669,027
Proceeds from sale of common stock, net of issuance costs 0 55,693,022
Proceeds from warrant exercise 880 0
Net cash provided (used) in financing activities (9,253,125) 87,362,049
Effect of currency rate exchange on cash and cash equivalents (1,970) 1,081
Net increase (decrease) in cash and cash equivalents (12,760,438) 84,437,651
Cash and cash equivalents at beginning of the period 85,400,656 2,202,106
Cash and cash equivalents at end of the period 72,640,218 86,639,757
Supplemental disclosure of cash flows information:    
Cash paid during the periods for income taxes 0 1,600
Cash paid during the periods for interest 0 509
Non-cash equity issuance costs $ 0 $ 34,477,000

Source